BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9112383)

  • 1. Inhibitory effects of tenilsetam on the Maillard reaction.
    Shoda H; Miyata S; Liu BF; Yamada H; Ohara T; Suzuki K; Oimomi M; Kasuga M
    Endocrinology; 1997 May; 138(5):1886-92. PubMed ID: 9112383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation.
    Münch G; Taneli Y; Schraven E; Schindler U; Schinzel R; Palm D; Riederer P
    J Neural Transm Park Dis Dement Sect; 1994; 8(3):193-208. PubMed ID: 7748463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction.
    Yamada H; Miyata S; Igaki N; Yatabe H; Miyauchi Y; Ohara T; Sakai M; Shoda H; Oimomi M; Kasuga M
    J Biol Chem; 1994 Aug; 269(32):20275-80. PubMed ID: 8051120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of a glucose-derived Maillard reaction product in the human lens.
    Nagaraj RH; Sady C
    FEBS Lett; 1996 Mar; 382(3):234-8. PubMed ID: 8605976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.
    Hoffmann J; Alt A; Lin J; Lochnit G; Schubert U; Schleicher E; Chavakis T; Brownlee M; Van der Woude FJ; Preissner KT; Hammes HP
    Thromb Haemost; 2006 Apr; 95(4):689-95. PubMed ID: 16601840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.
    Babu PV; Sabitha KE; Srinivasan P; Shyamaladevi CS
    Pharmacol Res; 2007 May; 55(5):433-40. PubMed ID: 17336542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo.
    Portero-Otin M; Nagaraj RH; Monnier VM
    Biochim Biophys Acta; 1995 Feb; 1247(1):74-80. PubMed ID: 7873594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
    Soulis-Liparota T; Cooper ME; Dunlop M; Jerums G
    Diabetologia; 1995 Apr; 38(4):387-94. PubMed ID: 7796978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
    Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
    Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo.
    Portero-Otín M; Pamplona R; Bellmunt MJ; Bergua M; Nagaraj RH; Prat J
    Life Sci; 1997; 60(4-5):279-87. PubMed ID: 9010483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrraline Formation Modulated by Sodium Chloride and Controlled by Encapsulation with Different Coating Materials in the Maillard Reaction.
    Liang Z; Chen X; Yang Z; Lai Y; Yang Y; Lei C; Zeng Y
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31717655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3-deoxyglucosone on the Maillard reaction.
    Igaki N; Sakai M; Hata H; Oimomi M; Baba S; Kato H
    Clin Chem; 1990 Apr; 36(4):631-4. PubMed ID: 2157564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of advanced Maillard reaction products and their pathological role.
    Monnier VM; Nagaraj RH; Portero-Otin M; Glomb M; Elgawish AH; Sell DR; Friedlander MA
    Nephrol Dial Transplant; 1996; 11 Suppl 5():20-6. PubMed ID: 9044302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
    Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
    Smith MA; Taneda S; Richey PL; Miyata S; Yan SD; Stern D; Sayre LM; Monnier VM; Perry G
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5710-4. PubMed ID: 8202552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes.
    Nagaraj RH; Portero-Otin M; Monnier VM
    Arch Biochem Biophys; 1996 Jan; 325(2):152-8. PubMed ID: 8561492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen.
    Nagaraj RH; Kern TS; Sell DR; Fogarty J; Engerman RL; Monnier VM
    Diabetes; 1996 May; 45(5):587-94. PubMed ID: 8621008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic control and in vivo non-oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients.
    Portero-Otín M; Pamplona R; Bellmunt MJ; Bergua M; Prat J
    Eur J Clin Invest; 1997 Sep; 27(9):767-73. PubMed ID: 9352249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.
    Nyengaard JR; Chang K; Berhorst S; Reiser KM; Williamson JR; Tilton RG
    Diabetes; 1997 Jan; 46(1):94-106. PubMed ID: 8971088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Maillard reaction and food allergies: is there a link?
    Toda M; Heilmann M; Ilchmann A; Vieths S
    Clin Chem Lab Med; 2014 Jan; 52(1):61-7. PubMed ID: 23492561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.